Commission Implementing Regulation (EU) 2025/2091 of 17 October 2025 laying down good manufacturing practice for veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Article 21Specifications and instructions
In force · version of Jul 16, 2026
1.Specifications and instructions shall be laid down in an orderly fashion and shall be clearly drafted.
2.The specifications for the materials used in the production of veterinary medicinal products and for the finished product, as well as the manufacturing instructions shall be adequate to ensure compliance with the terms of the marketing authorisation and the required level of quality. In particular, the following shall be duly documented: (a) specifications for active substances and other substances used in the manufacture of the veterinary medicinal product and for immediate packaging materials, including the following: — a description of the active substances or other substances used, including any relevant information required to avoid risk of error (e.g. use of internal codes), and identification of the approved supplier(s). Where relevant, reference to a pharmacopeial monograph shall be provided; — the quality and quantitative requirements as well as acceptance criteria, as appropriate; — instructions for sampling and testing, as appropriate; — storage conditions and, where applicable, any special handling precautions; — the maximum period of storage; (b) specifications for intermediate products and bulk products, including release criteria and the maximum period of storage, shall be set out for critical stages and when those products are purchased or dispatched; (c) specifications for finished products, in particular: — the name or identification of the product and, where applicable, the reference code; — a description of the pharmaceutical form and packaging; — instructions for sampling and testing; — the qualitative and quantitative requirements with acceptance limits; — storage conditions and, where applicable, any special handling precautions; — the shelf-life; (d) manufacturing instructions (including a description of the principal equipment to be used) and in-process controls, including the following: — the name of the product, with a product reference code relating to its specification; — a description of the pharmaceutical form, strength of the product and batch size; — a list of all materials to be used and the relevant amounts of each; — an indication of the expected final yield with the acceptable limits and, where applicable, of relevant intermediate yields; — an indication of the location where the relevant step should take place and the principal equipment to be used; — an indication of or reference to the methods to be used for preparing the critical equipment (e.g. cleaning, assembling, calibrating, sterilising); — detailed stepwise instructions to be followed (e.g. verification that equipment and workstation is clear of previous products, checks on materials, pre-treatments, sequence for adding materials, critical process parameters such as time, temperature, etc.); — instructions for any in-process controls, together with their limits; — where necessary, the requirements for bulk storage of the products, including the container, labelling and, where applicable, special storage conditions; — any special precautions to be observed; (e) packaging instructions for each veterinary medicinal product and pack size, including: — the name of the product as well as the batch number of the bulk product and finished product; — a description of its pharmaceutical form, and strength where applicable; — the pack size expressed in terms of the number, weight or volume of the product in the final container; — a complete list of all the packaging materials required, including quantities, sizes and types, with the code or reference number relating to the specification of each packaging material; — relevant instructions with an indication of the equipment to be used, and relevant precautions, including the need for a careful examination of the area and equipment in order to ascertain the line clearance before operations begin; — details of in-process controls with instructions for sampling and acceptance limits.
3.Documents containing specifications and instructions, including any changes thereto, shall be approved, signed and dated by authorised persons and the date of entry into operation shall be defined. Steps shall be taken to ensure that only the current version of a document is used.